As a part of the multinational clinical trial, an innovative device for ischemic stroke patients will be tested under GCT management in Russia and Romania.

GCT and Sponsor have jointly conducted a series of site qualification visits during the past two months.

As a result, a number of competent sites were selected to participate in the project and our teams are currently preparing for the regulatory submissions.